BridgeMD
New treatment option for Respiratory Failure
Official title Personalized Ultrasound-Guided External Diaphragm Pacing to Improve Outcomes in Invasive Mechanically Ventilated Patients
ClinicalTrials.gov ID: NCT06609577
What this study is testing
- What it's testing
- This study aims to explore whether personalized external diaphragm pacing (EDP) guided by real-time diaphragm ultrasound (DU) can improve outcomes for patients on invasive mechanical ventilation. Diaphragm ultrasound will be used to assess each patient's diaphragm function and adjust the pacing intensity, creating a customized treatment plan.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 95
You may be able to join if
- Adults ≥18 years of age undergoing invasive mechanical ventilation.
- Expected duration of mechanical ventilation ≥48 hours.
You likely can't join if
- ICU expected length of stay less than 48 hours
- severe phrenic nerve or diaphragmatic injury that is unable to respond to diaphragmatic pacing.
- Patients who have received or are scheduled to receive other respiratory assistance or diaphragmatic pacing interventions.
- Patients with end-stage disease with an expected survival of \<6 months.
- Patients who are unable to be weaned from mechanical ventilation, such as patients with severe brain injury or paraplegia.
The study team makes the final eligibility decision.
Where it's taking place
- Nantong, Jiangsu, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 95 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Nantong, Jiangsu, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.